| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |